Teachers Retirement System of The State of Kentucky Sells 1,457 Shares of Zoetis Inc. (NYSE:ZTS)

Teachers Retirement System of The State of Kentucky trimmed its holdings in shares of Zoetis Inc. (NYSE:ZTSGet Rating) by 4.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 33,490 shares of the company’s stock after selling 1,457 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Zoetis were worth $6,316,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Shorepoint Capital Partners LLC lifted its position in shares of Zoetis by 0.9% during the fourth quarter. Shorepoint Capital Partners LLC now owns 6,273 shares of the company’s stock worth $1,531,000 after purchasing an additional 54 shares during the last quarter. Bell Investment Advisors Inc increased its stake in shares of Zoetis by 17.5% during the fourth quarter. Bell Investment Advisors Inc now owns 382 shares of the company’s stock valued at $93,000 after buying an additional 57 shares during the period. Rehmann Capital Advisory Group increased its stake in shares of Zoetis by 1.7% during the fourth quarter. Rehmann Capital Advisory Group now owns 3,559 shares of the company’s stock valued at $869,000 after buying an additional 58 shares during the period. Salvus Wealth Management LLC increased its stake in shares of Zoetis by 3.9% during the first quarter. Salvus Wealth Management LLC now owns 1,631 shares of the company’s stock valued at $308,000 after buying an additional 61 shares during the period. Finally, Telemus Capital LLC increased its stake in shares of Zoetis by 4.0% during the first quarter. Telemus Capital LLC now owns 1,753 shares of the company’s stock valued at $331,000 after buying an additional 67 shares during the period. 91.05% of the stock is currently owned by institutional investors.

Zoetis Price Performance

ZTS opened at $157.30 on Friday. The business’s 50-day moving average is $169.18 and its two-hundred day moving average is $174.69. Zoetis Inc. has a 1 year low of $154.18 and a 1 year high of $249.27. The company has a debt-to-equity ratio of 1.14, a current ratio of 2.18 and a quick ratio of 1.46. The firm has a market capitalization of $73.64 billion, a PE ratio of 35.67, a price-to-earnings-growth ratio of 2.78 and a beta of 0.77.

Zoetis (NYSE:ZTSGet Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.22 by ($0.02). Zoetis had a return on equity of 49.03% and a net margin of 26.14%. The business had revenue of $2.10 billion for the quarter, compared to analysts’ expectations of $2.03 billion. During the same quarter in the previous year, the firm posted $1.19 EPS. Zoetis’s revenue was up 7.8% on a year-over-year basis. Research analysts anticipate that Zoetis Inc. will post 5.01 earnings per share for the current fiscal year.

Insider Transactions at Zoetis

In other news, CEO Kristin C. Peck sold 311 shares of the business’s stock in a transaction dated Thursday, July 7th. The stock was sold at an average price of $180.00, for a total transaction of $55,980.00. Following the sale, the chief executive officer now owns 39,743 shares in the company, valued at $7,153,740. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Kristin C. Peck sold 311 shares of Zoetis stock in a transaction dated Thursday, July 7th. The stock was sold at an average price of $180.00, for a total transaction of $55,980.00. Following the completion of the sale, the chief executive officer now owns 39,743 shares of the company’s stock, valued at $7,153,740. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kristin C. Peck sold 9,689 shares of Zoetis stock in a transaction dated Thursday, July 21st. The stock was sold at an average price of $180.00, for a total value of $1,744,020.00. Following the sale, the chief executive officer now directly owns 39,743 shares of the company’s stock, valued at approximately $7,153,740. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 16,501 shares of company stock worth $2,949,073. Insiders own 0.12% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on ZTS. Piper Sandler began coverage on Zoetis in a research note on Monday, July 11th. They set an “overweight” rating and a $205.00 price target on the stock. Stifel Nicolaus cut their price target on Zoetis from $275.00 to $225.00 and set a “buy” rating on the stock in a research note on Friday, June 24th. StockNews.com upgraded Zoetis from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 9th. William Blair restated an “outperform” rating on shares of Zoetis in a research note on Friday, August 5th. Finally, The Goldman Sachs Group cut their target price on Zoetis from $208.00 to $202.00 and set a “buy” rating on the stock in a research note on Thursday, July 21st. One research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Zoetis currently has an average rating of “Buy” and an average price target of $224.00.

Zoetis Profile

(Get Rating)

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Featured Articles

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTSGet Rating).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.